Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors.
Leukemia
; 29(2): 396-405, 2015 Feb.
Article
in En
| MEDLINE
| ID: mdl-24897508
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes, Regulatory
/
Sirolimus
/
Peripheral Blood Stem Cell Transplantation
/
Graft vs Host Disease
/
HLA Antigens
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2015
Document type:
Article
Affiliation country:
Country of publication: